BOSTON--(BUSINESS WIRE)--Aug. 17, 2020-- Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that it will webcast its Annual Meeting of Stockholders on Thursday, September 10, 2020, at 10:00 a.m. ET (5:00 p.m. Israel time) at 12 Leshem Street, Kiryat Gat, 8258412, Israel. During the meeting, Julian Adams, Ph.D., Gamida Cell’s chief executive officer, will present an overview of the company.

A live webcast of the meeting will be available in the “Investors & Media” section of Gamida Cell’s website at www.gamida-cell.com. To participate in the live call, please dial 866-930-5560 (U.S. domestic) or 409-216-0605 (international) and refer to conference ID number 8298307. A replay of the webcast will be available for approximately seven days.

About Gamida Cell 

Gamida Cell is an advanced cell therapy company committed to cures for patients with blood cancers and serious blood diseases. We harness our cell expansion platform to create therapies with the potential to redefine standards of care in areas of serious medical need. For additional information, please visit www.gamida-cell.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200817005081/en/

Investors:
Jaren Irene Madden
jaren@gamida-cell.com
1-617-286-6264

Media:
Matthew Corcoran
mcorcoran@tenbridgecommunications.com
1-617-866-7350

Source: Gamida Cell Ltd.